Back to search
FDAFDA · Food and drugs·Recall number D-0340-2018

Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMedics Pharma LLC, 6 Wheeling ROad, Dayton, NJ 08810. NDC 55150-202-00

Published February 14, 2018 · Recall initiated: December 4, 2017

Summary

FDA records drug Class I recall D-0340-2018, published February 14, 2018 and initiated December 4, 2017. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 66,100 vials; Lot: Lot # CPO170035. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass

What to do

Voluntary: Firm initiated · Letter

Get an email if PANTOPRAZOLE SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PANTOPRAZOLE SODIUM
Manufacturer
AuroMedics Pharma LLC
Distributor
Product was distributed nationwide in the USA
Lot
Lot # CPO170035
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMedics Pharma LLC, 6 Wheeling ROad, Dayton, NJ 08810. NDC 55150-202-00 recalled?

Yes. FDA published recall D-0340-2018 on February 14, 2018. Reported hazard: Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PANTOPRAZOLE SODIUM.